Author

Joshua R. Friedman 1

1 Janssen Research & Development, LLC,Spring House,United States

Effects of Ustekinumab Maintenance Therapy on Endoscopic Improvement and Histologic Improvement in the UNIFI Phase 3 Study in Ulcerative Colitis

Katherine Li, Joshua R. Friedman, Colleen W. Marano, Hongyan Zhang, Feifei Yang, William Sandborn, Bruce E. Sands, Brian G. Feagan, Laurent Peyrin-Biroulet, Gert De Hertogh

Microvilli length predicts clinical response to ustekinumab in Crohn's patients from the UNITI-2 trial

Kelli Van Dussen, Katherine Li, Kate Simpson, Brian Claggett, Joshua R. Friedman, Jacqueline Perrigoue, Thaddeus S. Stappenbeck

Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and colon transcriptomic analysis: results from the UNIFI phase 3 maintenance study

Katherine Li, Feifei Yang, Karen Hayden, David Strawn, Eric Wadman, Sunita Bhagat, Colleen W. Marano, Joshua R. Friedman

Item 1 - 3 / 3
1